The role of the sympathetic nervous system in obesity-related hypertension

被引:112
作者
da Silva, Alexandre A. [1 ]
do Carmo, Jussara [1 ]
Dubinion, John [1 ]
Hall, John E. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
关键词
ARTERIAL-PRESSURE; BLOOD-PRESSURE; FOOD-INTAKE; ANGIOTENSIN HYPERTENSION; MELANOCORTIN SYSTEM; METABOLIC SYNDROME; SODIUM RETENTION; CONTROLLED-TRIAL; RENAL-DISEASE; NITRIC-OXIDE;
D O I
10.1007/s11906-009-0036-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Obesity is recognized as a major health problem throughout the world. Excess weight is a major cause of increased blood pressure in most patients with essential hypertension and greatly increases the risk for diabetes, cardiovascular diseases, and end-stage renal disease. Although the mechanisms by which obesity raises blood pressure are not completely understood, increased renal sodium reabsorption, impaired pressure natriuresis, and volume expansion appear to play important roles. Several potential mechanisms have been suggested to contribute to altered kidney function and hypertension in obesity, including activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system, as well as physical compression of the kidneys, especially when visceral obesity is present. Activation of the sympathetic nervous system in obesity may be due, in part, to hyperleptinemia and other factors secreted by adipocytes and the gastrointestinal tract, activation of the central nervous system melanocortin pathway, and baroreceptor dysfunction.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 50 条
[41]   Comparison of strategies for sustaining weight loss - The weight loss maintenance randomized controlled trial [J].
Svetkey, Laura P. ;
Stevens, Victor J. ;
Brantley, Phillip J. ;
Appel, Lawrence J. ;
Hollis, Jack F. ;
Loria, Catherine M. ;
Vollmer, William M. ;
Gullion, Christina M. ;
Funk, Kristine ;
Smith, Patti ;
Samuel-Hodge, Carmen ;
Myers, Valerie ;
Lien, Lillian F. ;
Laferriere, Daniel ;
Kennedy, Betty ;
Jerome, Gerald J. ;
Heinith, Fran ;
Harsha, David W. ;
Evans, Pamela ;
Erlinger, Thomas P. ;
Dalcin, Arline T. ;
Coughlin, Janelle ;
Charleston, Jeanne ;
Champagne, Catherine M. ;
Bauck, Alan ;
Ard, Jamy D. ;
Aicher, Kathleen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (10) :1139-1148
[42]   Melanocortin-4 receptor mediates chronic cardiovascular and metabolic leptin [J].
Tallam, Lakshmi S. ;
da Silva, Alexandre A. ;
Hall, John E. .
HYPERTENSION, 2006, 48 (01) :58-64
[43]   Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia [J].
Tallam, LS ;
Stec, DE ;
Willis, MA ;
da Silva, AA ;
Hall, JE .
HYPERTENSION, 2005, 46 (02) :326-332
[44]  
Tanida M, 2007, EXP BIOL MED, V232, P390
[45]   Plasma angiotensinogen concentrations in obese patients [J].
Umemura, S ;
Nyui, N ;
Tamura, K ;
Hibi, K ;
Yamaguchi, S ;
Nakamaru, M ;
Ishigami, T ;
Yabana, M ;
Kihara, M ;
Inoue, S ;
Ishii, M .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (06) :629-633
[46]   Adiponectin, cardiovascular function, and hypertension [J].
Wang, Zhao V. ;
Scherer, Philipp E. .
HYPERTENSION, 2008, 51 (01) :8-14
[47]   Weight change and duration of overweight and obesity in the incidence of type 2 diabetes [J].
Wannamethee, SG ;
Shaper, AG .
DIABETES CARE, 1999, 22 (08) :1266-1272
[48]   Overweight and obesity as determinants of cardiovascular risk - The Framingham experience [J].
Wilson, PWF ;
D'Agostino, RB ;
Sullivan, L ;
Parise, H ;
Kannel, WB .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (16) :1867-1872
[49]   Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects [J].
Wofford, MR ;
Anderson, DC ;
Brown, CA ;
Jones, DW ;
Miller, ME ;
Hall, JE .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (07) :694-698
[50]   Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation [J].
Xu, Xiangbin ;
Jhun, Bong Sook ;
Ha, Chang Hoon ;
Jin, Zheng-Gen .
ENDOCRINOLOGY, 2008, 149 (08) :4183-4192